Table 4.
Reported adverse events by site
| Adverse event | Study site | Total | |||
|---|---|---|---|---|---|
| Kibaha | Mlimba | Mkuzi | Ujiji | ||
| Cough | 5 (23.81) | 3 (27.27) | 13 (76.47) | 11 (37.93) | 32 (41.02) |
| Abdominal pain | 6 (28.57) | 2 (18.18) | 1 (5.88) | 0 (0) | 9 (11.54) |
| Running nose | 4 (19.05) | 2 (18.18) | 0 (0) | 3 (10.34) | 9 (11.54) |
| Fever | 3 (14.29) | 2 (18.18) | 0 (0) | 3 (10.34) | 8 (10.26) |
| Vomiting | 1 (4.76) | 0 (0) | 0 (0) | 6 (20.69) | 7 (8.97) |
| Diarrhoea | 0 (0) | 1 (9.09) | 2 (11.76) | 3 (10.34) | 6 (7.69) |
| Painful micturition | 2 (9.52) | 0 (0) | 0 (0) | 3 (10.34) | 5 (6.41) |
| Anal itching | 0 (0) | 0 (0) | 1 (5.88) | 0 (0) | 1 (1.28) |
| Anaemia | 0 (0) | 1 (9.09) | 0 (0) | 0 (0) | 1 (1.28) |
| Total | 21 (100) | 11 (100) | 17 (100) | 29 (100) | 78 (100) |